Pages

Thursday, October 26, 2017

Imprimis Launches Surface Pharmaceuticals Subsidiary

Imprimis Launches Surface Pharmaceuticals Subsidiary: The markets for Surface's drug candidates include dry eye disease and blepharitis.

No comments:

Post a Comment